Form 8-K - Current report:
SEC Accession No. 0001415889-15-001874
Filing Date
2015-05-22
Accepted
2015-05-22 17:23:05
Documents
1
Period of Report
2015-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vsta8k_may202015.htm 8-K 24564
  Complete submission text file 0001415889-15-001874.txt   25785
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54014 | Film No.: 15887556
SIC: 2834 Pharmaceutical Preparations